The latest report by IMARC Group, titled “Hemostats Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global hemostats market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.73% during 2024-2032.
Hemostats are medical instruments designed to control bleeding or hemorrhage during surgical procedures. They function by clamping or compressing blood vessels or tissue to prevent excessive blood flow. They are available in various forms. The most recognizable is the hemostatic clamp, a scissor-like tool with serrated jaws that can grip and constrict vessels. Besides physical instruments, "hemostat" also refers to hemostatic agents. These substances promote clotting and can be applied directly to wounds to stem the bleeding. They work by accelerating the natural clotting cascade or providing a physical matrix that aids clot formation. Common hemostatic agents include gelatins, collagens, and oxidized cellulose. As surgical procedures evolve, there has been a rise in the need for effective hemostasis. By promptly controlling bleeding, hemostats reduce complications, improve surgical outcomes, and save lives by preventing significant blood loss. Currently, hemostats are gaining immense traction across the globe due to the rising number of surgeries and the increasing need for efficient wound management solutions.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/hemostats-market/requestsample
Hemostats Market: Report Trends and Drivers:
The global hemostats market is primarily driven by the increasing prevalence of surgical procedures, driven by the rising aging population, and the expansion of healthcare infrastructure. Additionally, rapid advancements in medical technology, including the development of innovative and more effective hemostatic products, are propelling market growth. Apart from this, the growing awareness among healthcare professionals regarding the benefits of using hemostats to reduce bleeding during surgeries has accelerated their adoption rate. Moreover, rising trauma cases, particularly in emerging economies, have catalyzed market growth. Furthermore, increasing strategic collaborations and partnerships between pharmaceutical companies and healthcare institutions that improve the accessibility and distribution of hemostatic products across the globe are contributing to market growth. Other factors, including increasing focus on minimally invasive surgical techniques, heightening awareness about hemostat benefits in dental procedures, and rising investments in healthcare infrastructure, are also anticipated to drive the market further.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Thrombin Based
- Combination Based
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
Breakup by Application:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
Breakup by Formulation:
- Matrix and Gel Hemostats
- Sheet and Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Arch Therapeutics Inc.
- Baxter International Inc.
- B. Braun Melsungen Aktiengesell
- C. R. Bard Inc.
- GELITA MEDICAL GmbH
- Integra LifeSciences Corporation
- Johnson & Johnson
- Pfizer Inc.
- Stryker Corporation
- Teleflex Incorporated
- Z-Medica LLC
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
